PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. Rademaker G, Hernandez GA, Seo Y, Dahal S, et al. Nature 2025 May 21. doi: 10.1038/s41586-025-09017.

Read + Share

Amedeo Smart

Independent Medical Education

Rademaker G, Hernandez GA, Seo Y, Dahal S, et al. PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. Nature 2025 May 21. doi: 10.1038/s41586-025-09017.
PMID: 40399683